文献速递乳腺MR

背景实质强化与乳腺癌:其作为影像生物标志物潜在应用的新证据综述

Background parenchymal enhancement and breast cancer: a review of the emerging evidences about its potential use as imaging biomarker.
PubMed 文献 · Br J Radiol · 2020-10-15

该系统综述检索截至2020年6月的文献,纳入22篇研究,评估对侧健康乳腺背景实质强化(BPE)与乳腺癌的关系。BPE与侵袭性、组织学类型、T/N分期、多灶性、淋巴血管侵犯及组织学分级无显著关联,与分子亚型关系尚不明确;新辅助化疗期间及之后BPE下降更明显与病理完全缓解相关;BPE作为预后因素的结果不一致;高BPE与微血管密度、CD34及VEGF相关。

要点

  • 对侧健康乳腺BPE与乳腺癌侵袭性、组织学类型、T/N分期、多灶性、淋巴血管侵犯及组织学分级无显著关联。
  • 新辅助化疗期间及之后BPE下降更明显与病理完全缓解相关,支持其作为预测生物标志物的潜力。
  • 高BPE与微血管密度、CD34及VEGF等血管化与血管生成组织学标志物相关。

核心结论

  • 对侧乳腺BPE在多个方面与乳腺癌相关,因此已被提出作为细化乳腺癌决策过程的工具。
  • 需要采用标准化BPE评估的更多研究,才能将这一新兴生物标志物转化到个性化医疗时代的临床实践中。

研究设计与样本

  • 系统综述,计算机文献检索使用PubMed和Google Scholar,检索截至2020年6月。
  • 由两位作者独立进行检索、筛选、质量评估和数据提取。
  • 共识别476篇文章,其中22篇符合纳入标准。
  • 使用修订版诊断准确性研究质量评估工具(QUADAS)评估研究质量和偏倚风险。

诊断标准与关键数值

  • BPE与侵袭性、组织学癌类型、T分期和N分期、多灶性、淋巴管和血管侵犯及组织学肿瘤分级之间未发现显著关联。
  • BPE与分子亚型之间的关联仍不明确。
  • 作为预测生物标志物,新辅助化疗期间和之后BPE下降更明显与病理完全缓解相关。
  • 关于BPE作为预后因素作用的结果不一致。
  • 发现高BPE与微血管密度、CD34和VEGF(血管化和血管生成的组织学标志物)之间存在关联。

局限性

  • 需要采用标准化BPE评估的更多研究,才能将这一新兴生物标志物转化到临床实践中。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To conduct a systematic review of evidences about the relationship between background parenchymal enhancement (BPE) of the contralateral healthy breast and breast cancer: its association with clinicopathological breast cancer characteristics, its potential as predictive and prognostic biomarker and the biological linkage between BPE and breast cancer.

METHODS: A computerized literature search using PubMed and Google Scholar was performed up to June 2020. Two authors independently conducted search, screening, quality assessment, and extraction of data from the eligible studies. Studies were assessed for quality and risk of bias using the revised Quality Assessment of Diagnostic Accuracy Studies tool.

RESULTS: Of the 476 articles identified, 22 articles met the inclusion criteria. No significant association was found between BPE and invasiveness, histological cancer type, T- and N-stage, multifocality, lymphatic and vascular invasion and histological tumour grade while the association between BPE and molecular subtypes is still unclear. As predictive biomarker, a greater decrease in BPE during and after neoadjuvant chemotherapy was associated with pathological complete response. Results about the role of BPE as prognostic factor were inconsistent. An association between high BPE and microvessel density, CD34 and VEGF (histological markers of vascularization and angiogenesis) was found.

CONCLUSIONS: BPE of the contralateral breast is associated with breast cancer in several aspects, therefore it has been proposed as a tool to refine breast cancer decision-making process.

ADVANCES IN KNOWLEDGE: Additional researches with standardized BPE assessment are needed to translate this emerging biomarker into clinical practice in the era of personalized medicine.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Rella R, Contegiacomo A, Bufi E, et al. Background parenchymal enhancement and breast cancer: a review of the emerging evidences about its potential use as imaging biomarker. Br J Radiol. 2020. PMID: 33035073. doi:10.1259/bjr.20200630

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。